Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tourmaline Bio, Inc. - Common Stock (NQ: TRML ) 16.96 +0.36 (+2.17%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 174,882 Open 16.64 Bid (Size) 16.96 (1) Ask (Size) 20.00 (10) Prev. Close 16.60 Today's Range 16.44 - 17.19 52wk Range 9.180 - 48.31 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Tourmaline Bio to Present at the Jefferies Global Healthcare Conference May 23, 2024 From Tourmaline Bio, Inc. Via GlobeNewswire Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial May 16, 2024 From Tourmaline Bio, Inc. Via GlobeNewswire Performance YTD -36.00% -36.00% 1 Month +13.07% +13.07% 3 Month -57.61% -57.61% 6 Month -10.74% -10.74% 1 Year +55.60% +55.60% More News Read More TRML Stock Earnings: Tourmaline Bio Beats EPS for Q1 2024 May 13, 2024 Via InvestorPlace Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights May 13, 2024 From Tourmaline Bio, Inc. Via GlobeNewswire TRML Stock Earnings: Tourmaline Bio Reported Results for Q4 2023 March 19, 2024 Via InvestorPlace Avalo Therapeutics Appoints Biotech Leaders to Board of Directors April 02, 2024 From Avalo Therapeutics Via GlobeNewswire Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session March 21, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session March 21, 2024 Via Benzinga Dow Jumps 200 Points; US Weekly Jobless Claims Fall March 21, 2024 Via Benzinga Topics Stocks Exposures US Equities Argenx, Immunovant Soar — As Tourmaline Plummets — On A Rival's Lackluster Test Results March 21, 2024 Via Investor's Business Daily 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 21, 2024 Via Benzinga Five Below Posts Q4 Results, Joins LexinFintech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session March 21, 2024 Via Benzinga Topics Stocks Exposures US Equities Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights March 19, 2024 From Tourmaline Bio, Inc. Via GlobeNewswire Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares January 29, 2024 From Tourmaline Bio, Inc. Via GlobeNewswire Tourmaline Bio Announces Pricing of Public Offering of Common Stock January 25, 2024 From Tourmaline Bio, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session January 24, 2024 Via Benzinga Tourmaline Bio Announces Proposed Public Offering of Common Stock January 24, 2024 From Tourmaline Bio, Inc. Via GlobeNewswire Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD) January 08, 2024 From Tourmaline Bio, Inc. Via GlobeNewswire TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday January 03, 2024 Via Benzinga Topics Stocks Exposures US Equities Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals December 29, 2023 Via MarketBeat Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday December 22, 2023 Via Benzinga Topics Stocks Exposures US Equities Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 22, 2023 Via Benzinga Tourmaline Bio added to the NASDAQ Biotechnology Index December 15, 2023 From Tourmaline Bio, Inc. Via GlobeNewswire Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board December 14, 2023 From Tourmaline Bio, Inc. Via GlobeNewswire Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday October 31, 2023 Via Benzinga Topics Stocks Exposures US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
